About Icosagen
Icosagen is a company based in Tartu (Estonia) founded in 2005. Icosagen offers products and services including Antibody Discovery, Protein Production, Cell Line Development, and GMP Manufacturing. Icosagen operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Tartu, Estonia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oü Relade
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.32 M (USD), Grant
Aug 31, 2018
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Icosagen
Icosagen offers a comprehensive portfolio of products and services, including Antibody Discovery, Protein Production, Cell Line Development, and GMP Manufacturing.
Platform for discovering antibodies through techniques like phage display.
Service for producing recombinant proteins with quality control.
Process for creating stable cell lines for protein expression.
Manufacturing of proteins under GMP standards for clinical use.
People of Icosagen
Unlock access to complete
Funding Insights of Icosagen
Investors in Icosagen
Icosagen has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Icosagen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Icosagen
Investment portfolio details for Icosagen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Icosagen
Detailed financials for Icosagen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Icosagen Comparisons
Peer comparison for Icosagen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Icosagen
Icosagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of Icosagen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Icosagen
Complete news archive for Icosagen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Icosagen
Icosagen was founded in 2005 and raised its 1st funding round 10 years after it was founded.
Icosagen is headquartered in Tartu, Estonia.
Icosagen was founded in 2005 in Tartu, Estonia, and operates in the biotechnology sector. Recombinant protein and antibody production services are offered, along with antibody development for research purposes. The product portfolio encompasses antibodies, proteins, ELISA kits, transfection reagents, and DNARNA isolation kits. A technology platform known as Icocell is being developed to enhance cell line generation compatible with industrial cell factory processes.
Icosagen's top competitors include Sino Biological, GenScript and Y-Biologics.
Icosagen offers Antibody Discovery, Protein Production, Cell Line Development, and GMP Manufacturing.
Icosagen has 2 investors. Key investors include European Union, and EIC Fund.